Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer

Fibrosing cholestatic hepatitis (FCH) is a variant of viral hepatitis reported in hepatitis B virus or hepatitis C virus infected liver, renal or bone transplantation recipients and in leukemia and lymphoma patients after conventional cytotoxic chemotherapy. FCH constitutes a well-described form of...

Descripción completa

Detalles Bibliográficos
Autores: Ceballos-Viro, J. (Jaime)|||/items/f69e8eca-5cc9-4482-a69a-1c95aee1d7b4, Lopez-Picazo, J.M. (José María)|||/items/1a2fbd26-96ec-4587-b2d2-8f6ea1f707de, Perez-Gracia, J.L. (Jose Luis)|||/items/7be82c5d-4858-4e04-bd77-7ef5a883021b, Sola, J.J. (Jesús Javier)|||/items/5e9c3448-a06b-4c18-ac7a-1f314af02493, Aisa, G. (Gregorio)|||/items/495df392-8169-4197-b890-469d4407da42, Gil-Bazo, I. (Ignacio)|||/items/a92277a7-0a96-4e2f-9bb0-8ac5d222270b
Tipo de recurso: artículo
Fecha de publicación:2009
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/22553
Acceso en línea:https://hdl.handle.net/10171/22553
Access Level:acceso abierto
Palabra clave:Fibrosing cholestatic hepatitis
Immunosuppression
Lung cancer
Descripción
Sumario:Fibrosing cholestatic hepatitis (FCH) is a variant of viral hepatitis reported in hepatitis B virus or hepatitis C virus infected liver, renal or bone transplantation recipients and in leukemia and lymphoma patients after conventional cytotoxic chemotherapy. FCH constitutes a well-described form of fulminant hepatitis having ex-- of a 49-year-old patient diagnosed with small-cell lung cancer who developed this condition following conventional chemotherapy-induced immunosuppression. This conventional chemotherapy for a solid tumor. In addition to a detailed report of the case, a physiopathological examination of this potentially life-threatening condition and its treatment options are discussed.

Similares en LA Referencia